MODERATE TO SEVERE PLAQUE PSORIASIS
Clinical trials for MODERATE TO SEVERE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug boost psoriasis treatment? new trial investigates
Disease control Not yet recruitingThis study tests whether adding metformin (a diabetes drug) to secukinumab (a standard psoriasis medication) works better than secukinumab alone for treating moderate-to-severe plaque psoriasis in overweight or obese Chinese adults. About 186 participants will receive either the …
Matched conditions: MODERATE TO SEVERE PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New psoriasis pill shows promise in major trial
Disease control Not yet recruitingThis study tests a new tablet called CMS-D001 for adults with moderate to severe plaque psoriasis. About 540 people will take either the drug or a placebo to see if it improves skin symptoms like redness and scaling. The goal is to find a safe and effective treatment option.
Matched conditions: MODERATE TO SEVERE PLAQUE PSORIASIS
Phase: PHASE2, PHASE3 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 11, 2026 20:47 UTC